{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T15:09:43Z","timestamp":1773241783627,"version":"3.50.1"},"reference-count":14,"publisher":"SynthesisHub Advance Scientific Research","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Cardiovascular Disease Research"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.jcdr.2012.10.001","type":"journal-article","created":{"date-parts":[[2013,8,14]],"date-time":"2013-08-14T21:08:15Z","timestamp":1376514495000},"page":"7-10","source":"Crossref","is-referenced-by-count":9,"title":["Prevalence and significance of electrocardiographic changes and side effect profile of regadenoson compared with adenosine during myocardial perfusion imaging"],"prefix":"10.31838","volume":"4","author":[{"given":"Maliha","family":"Zahid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaysha","family":"Kapila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecelia E.","family":"Eagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Yusko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwin D.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl D.","family":"Missenda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"17074","reference":[{"key":"10.1016\/j.jcdr.2012.10.001_bib1","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/S1071-3581(96)90205-6","article-title":"Pharmacology of coronary vasodilation: a brief review","volume":"3","author":"Orlandi","year":"1996","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.jcdr.2012.10.001_bib2","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/j.jacc.2005.05.097","article-title":"Initial clinical experience with regadenoson, a novel selective A2A agonist for pharmacologic stress single-photon emission computed tomography myocardial perfusion imaging","volume":"46","author":"Hendel","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcdr.2012.10.001_bib3","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.nuclcard.2007.06.114","article-title":"Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the\u00a0ADVANCE phase 3 multicenter international trial","volume":"14","author":"Iskandrian","year":"2007","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.jcdr.2012.10.001_bib4","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jcmg.2009.04.011","article-title":"Regadenoson induces comparable left ventricular perfusion defects as adenosine: a quantitative analysis from the ADVANCE MPI 2 trial","volume":"2","author":"Mahmarian","year":"2009","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcdr.2012.10.001_bib5","article-title":"Hemodynamic response, arrhythmic risk, and overall safety of regadenoson as a pharmacologic stress agent for myocardial perfusion imaging in chronic obstructive pulmonary disease and bronchial asthma patients","author":"Husain","year":"2011","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.jcdr.2012.10.001_bib6","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.nuclcard.2008.02.009","article-title":"Safety of regadenoson, an adenosine A2A receptor agonist for myocardial perfusion imaging, in mild asthma and moderate asthma patients: a randomized, double-blind, placebo-controlled trial","volume":"15","author":"Leaker","year":"2008","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.jcdr.2012.10.001_bib7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s12350-011-9508-3","article-title":"A\u00a0randomized, double-blind, placebo-controlled study of the safety and tolerance of regadenoson in subjects with stage 3 or 4 chronic kidney disease","volume":"19","author":"Ananthasubramaniam","year":"2012","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.jcdr.2012.10.001_bib8","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s12350-011-9378-8","article-title":"Safety of regadenoson as a pharmacologic stress agent for myocardial perfusion imaging in chronic kidney disease patients not on hemodialysis","volume":"18","author":"Palani","year":"2011","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.jcdr.2012.10.001_bib9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.amjcard.2009.08.663","article-title":"Safety of regadenoson in patients with end-stage renal disease","volume":"105","author":"Aljaroudi","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcdr.2012.10.001_bib10","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s12350-011-9399-3","article-title":"Regadenoson is a safe and well-tolerated pharmacological stress agent for myocardial perfusion imaging in post-heart transplant patients","volume":"18","author":"Cavalcante","year":"2011","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.jcdr.2012.10.001_bib11","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12350-010-9288-1","article-title":"Safety of\u00a0regadenoson in patients with end-stage liver disease","volume":"18","author":"Aljaroudi","year":"2011","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.jcdr.2012.10.001_bib12","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1161\/01.CIR.87.4.1211","article-title":"Angiographic and hemodynamic determinants of myocardial ischemia during adenosine thallium-201 scintigraphy in coronary artery disease","volume":"87","author":"Nishimura","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.jcdr.2012.10.001_bib13","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0002-9149(99)80234-3","article-title":"Adenosine radionuclide perfusion imaging in the preoperative evaluation of patients undergoing peripheral vascular surgery","volume":"76","author":"Marshall","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcdr.2012.10.001_bib14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1067\/mnc.2002.127625","article-title":"Prognostic significance of ischemic electrocardiographic changes during adenosine infusion in patients with normal myocardial perfusion imaging","volume":"10","author":"Abbott","year":"2003","journal-title":"J\u00a0Nucl Cardiol"}],"container-title":["Journal of Cardiovascular Disease Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T13:25:06Z","timestamp":1585229106000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0975358313000259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0975358313000259"],"URL":"https:\/\/doi.org\/10.1016\/j.jcdr.2012.10.001","relation":{},"ISSN":["0975-3583"],"issn-type":[{"value":"0975-3583","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}